← feed

Is NCT02709850 results overdue?

Yes — results are overdue. Primary completion was 2017-04-12; the FDAAA-801 reporting deadline (2018-04-12) passed 2992 days ago and no results are posted on ClinicalTrials.gov.

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of IONIS ANGPTL3-LRx in Healthy Volunteers With Elevated Triglycerides and Participants With Familial Hypercholesterolemia

NCT IDNCT02709850 ↗
SponsorIonis Pharmaceuticals, Inc. (INDUSTRY)
Public issuerIONIS PHARMACEUTICALS INC — IONS (CIK 0000874015) best-effort name match, 95% conf — verify on EDGAR ↗
PhasePHASE1
StatusCOMPLETED
Primary completion2017-04-12 (ACTUAL)
Reporting deadline2018-04-12 (completion + 365d)
Days overdue2992
Results postedNo — check results tab ↗
FDA-regulateddrug: yes, device: no
ProvenanceFlagged overdue on 2026-06-21 · SHA-256 064b5993e0759924… (hash-chained, tamper-evident)

Source of record: ClinicalTrials.gov NCT02709850. The reporting requirement is FDAAA 801 (Public Law 110-85 §801) and the Final Rule, 42 CFR Part 11.

⚠ Public-record facts from ClinicalTrials.gov — not a finding of violation, fraud, or non-compliance, and not legal or investment advice. Full disclaimer →